Lemtrada, a drug from Sanofi meant to treat multiple sclerosis, has been rejected by the FDA, which has called for more clinical trials. More
- ADVERTISEMENT
-
-
Sponsored By:
- Poll of the Day
- Partners
- ADVERTISEMENT
SNY
Recent Articles
End 2013 on a High Note With These 58 Stock Trades
Heading into the end of the year means looking through opportunities to make both buy and sell stock trades. Here are 58 updated rankings to get started More
EA Falls, but Chart Remains Constructive
Video game maker EA fell hard on Friday. However, the medium-term charts remain constructive, thanks to lots of buzz around gaming consoles. More
3 Huge Healthcare Trends Can Fatten Your Portfolio
Healthcare concerns in the U.S. are being addressed by companies in the industry. These 3 issues can lead investors to stock opportunities More
You’ll Want To Read This If You Own SNY, TWC, or TRI
Recent earnings results from Sony (SNY), Time Warner Cable (TWC) and Thomson (TRI) led me to revisit my Portfolio Grader Ratings, and they are worth a look More
It May Be Time to Trim Away at Your Portfolio
The stock market is doing well for October, but its may be time to look through your portfolio in order to trim away some of the upcoming losers More
New Drug Could Cut ‘Bad’ Cholesterol Nearly in Half
Late stage trials of Alirocumab, an anti-cholesterol drug from Regeneron and Sanofi, showed promising results. More
